B iologisch jünger durch N ahrung !
S tudienreferenzen
Wang, Y., Chun, O. K., & Song, W. O. (2013). Plasma and dietary antioxidant status as cardiovascular disease risk factors: a review of human studies. Nu - trients, 5(8), 2969-3004. Serino, A., & Salazar, G. (2018). Protective Role of Polyphenols against Vas - cular Inflammation, Aging and Cardiovascular Disease. Nutrients, 11(1), 53. Unic A, Derek L, Hodak N, Marijancevic D, Ceprnja M, Serdar T, Krhac M, Romic Z. Endothelins - clinical perspectives. Biochem Med (Zagreb). 2011;21(3): 231-42. Piechota A, Polańczyk A, Goraca A. Role of endothelin-1 receptor blockers on hemodynamic parameters and oxidative stress. Pharmacol Rep. 2010 Jan- Feb; 62(1): 28-34. Vignon-Zellweger N, Heiden S, Miyauchi T, Emoto N. Endothelin and en - dothelin receptors in the renal and cardiovascular systems. Life Sci. 2012 Oct 15;91(13-14): 490-500. Rautureau Y, Schiffrin EL. Endothelin in hypertension: an update. Curr Opin Nephrol Hypertens. 2012 Mar;21(2):128-36. Kohan, D. E., Rossi, N. F., Inscho, E. W., & Pollock, D. M. (2011). Regulation of blood pressure and salt homeostasis by endothelin. Physiological reviews, 91(1), 1–77. Chester, A. H., & Yacoub, M. H. (2014). The role of endothelin-1 in pulmonary arterial hypertension. Global cardiology science & practice, 2014(2), 62–78. Smith, T. P., Haymond, T., Smith, S. N., & Sweitzer, S. M. (2014). Evidence for the endothelin system as an emerging therapeutic target for the treatment of chronic pain. Journal of pain research, 7, 531–545. Hans G, Schmidt BL, Strichartz G. Nociceptive sensitization by endothelin-1. Brain Res Rev. 2009 Apr; 60(1): 36-42.
Kowalczyk, A., Kleniewska, P., Kolodziejczyk, M., Skibska, B., & Goraca, A. (2014). The role of endothelin-1 and endothelin receptor antagonists in in - flammatory response and sepsis. Archivum immunologiae et therapiae ex - perimentalis, 63(1), 41–52. Nakahara T, Kido-Nakahara M, Ohno F, Ulzii D, Chiba T, Tsuji G, Furue M. The pruritogenic mediator endothelin-1 shifts the dendritic cell-T-cell re - sponse toward Th17/Th1 polarization. Allergy. 2018 Feb; 73(2): 511-515. Kolettis TM, Barton M, Langleben D, Matsumura Y. Endothelin in coronary artery disease and myocardial infarction. Cardiol Rev. 2013 Sep-Oct; 21(5): 249-56. Kawanabe, Y., & Nauli, S. M. (2010). Endothelin. Cellular and molecular life sciences : CMLS, 68(2), 195–203. Fagan, K. A., McMurtry, I. F., & Rodman, D. M. (2001). Role of endothelin-1 in lung disease. Respiratory research, 2(2), 90-101. Kohan, D. E., & Barton, M. (2014). Endothelin and endothelin antagonists in chronic kidney disease. Kidney international, 86(5), 896–904. Freeman, B. D., Machado, F. S., Tanowitz, H. B., & Desruisseaux, M. S. (2014). Endothelin-1 and its role in the pathogenesis of infectious diseases. Life sci - ences, 118(2), 110–119. Lteif A, Vaishnava P, Baron AD, Mather KJ. Endothelin limits insulin action in obese/insulin-resistant humans. Diabetes. 2007 Mar; 56(3): 728-34. Bagnato A, Spinella F, Rosanò L. Emerging role of the endothelin axis in ovar - ian tumor progression. Endocr Relat Cancer. 2005 Dec; 12(4): 761-72. Wouters J, Hunger RE, Garrod T, Dubuis B, Hunziker T, van den Oord JJ, Lahav-le Coutre R. First-in-Human Proof-of-Concept Study: Intralesional Administration of BQ788, an Endothelin Receptor B Antagonist, to Melanoma Skin Metastases. Oncologist. 2015 Oct; 20(10): 1121-2.
47
Made with FlippingBook - professional solution for displaying marketing and sales documents online